Evelyn L. Jara

Dr. Evelyn L. Jara

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MAMohammed M Alshehri
Mohammed M Alshehri
Javad Sharifi-RadJavad Sharifi-Rad
Javad Sharifi-Rad
JHJesús Herrera
Jesús Herrera
EJEvelyn L. Jara
Evelyn L. Jara
Luis SalazarLuis Salazar
Luis Salazar
William C. ChoWilliam C. Cho
William C. Cho
Daidzein is a phytoestrogen isoflavone found in soybeans and other legumes. The chemical composition of daidzein is analogous to mammalian estrogens, and it could be useful with a dual‐directional purpose by substituting/hindering with estrogen and estrogen receptor (ER) complex. Hence, daidzein puts forth shielding effects against a great number of diseases, especially those associated with the control of estrogen, such as breast cancer, diabetes, osteoporosis, and cardiovascular disease. However, daidzein also has other ER‐independent biological activities, such as oxidative damage reduction acting as an antioxidant, immune regulator as an anti‐inflammatory agent, and apoptosis regulation, directly linked to its potential anticancer effects. In this sense, the present review is aimed at providing a deepen analysis of daidzein pharmacodynamics and its implications in human health, from its best‐known effects alleviating postmenopausal symptoms to its potential anticancer and antiaging properties.

1 April 2017 in Immunology Letters
Verified
Journal Article
Closed access
EJEvelyn L. Jara
Evelyn L. Jara
NMNatalia Muñoz-Durango
Natalia Muñoz-Durango
CLCarolina Llanos
Carolina Llanos
CFCarlos Fardella
Carlos Fardella
Pablo Alberto GonzálezPablo Alberto González
Pablo Alberto González
CRClaudia A. Riedel
Claudia A. Riedel

1 September 2016 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Closed access
PDF file
JMJuan Pablo Mackern-Oberti
Juan Pablo Mackern-Oberti
EJEvelyn L. Jara
Evelyn L. Jara
CRClaudia A. Riedel
Claudia A. Riedel
AKAlexis Kalergis
Alexis Kalergis
Hormonal homeostasis is crucial for keeping a competent and healthy immune function. Several hormones can modulate the function of various immune cells such as dendritic cells (DCs) by influencing the initiation of the immune response and the maintenance of peripheral tolerance to self-antigens. Hormones, such as estrogens, prolactin, progesterone and glucocorticoids may profoundly affect DCs differentiation, maturation and function leading to either a pro-inflammatory or an anti-inflammatory (or tolerogenic) phenotype. If not properly regulated, these processes can contribute to the pathogenesis of autoimmune disease. An unbalanced hormonal status may affect the production of pro-inflammatory cytokines, the expression of activating/inhibitory receptors and co-stimulatory molecules on conventional and plasmacytoid DCs (pDCs), conferring susceptibility to develop autoimmunity. Estrogen receptor (ER)-α signaling in conventional DCs can promote IFN-α and IL-6 production and induce the expression of CD40, CD86 and MHCII molecules. Furthermore, estrogen modulates the pDCs response to Toll-like receptor ligands enhancing T cell priming. During lupus pathogenesis, ER-α deficiency decreased the expression of MHC II on pDCs from the spleen. In contrast, estradiol administration to lupus-prone female mice increased the expression of co-stimulatory molecules, enhanced the immunogenicity and produced large amounts of IL-6, IL-12 and TNF-α by bone marrow-derived DCs. These data suggest that estradiol/ER signaling may play an active role during lupus pathology. Similarly, understanding hormonal modulation of DCs may favor the design of new therapeutic strategies based on autologous tolerogenic DCs transfer, especially in sex-biased systemic autoimmune diseases. In this review, we discuss recent data relative to the role of different hormones (estrogen, prolactin, progesterone and glucocorticoids) in DC function during systemic autoimmune pathogenesis.

7 October 2019 in Immunology
Verified
Journal Article
Closed access
PDF file
SFSAMANTA FUNES
SAMANTA FUNES
MRMariana Ríos
Mariana Ríos
FGFelipe Gómez‐Santander
Felipe Gómez‐Santander
AFAyleen Fernández‐Fierro
Ayleen Fernández‐Fierro
MAMaría J. Altamirano‐Lagos
María J. Altamirano‐Lagos
AKAlexis Kalergis
Alexis Kalergis

27 November 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
KBKaren Bohmwald
Karen Bohmwald
JEJanyra A. Espinoza
Janyra A. Espinoza
RPRaúl A. Pulgar
Raúl A. Pulgar
EJEvelyn L. Jara
Evelyn L. Jara
AKAlexis Kalergis
Alexis Kalergis
The mononuclear phagocyte system (MPS) comprises of monocytes, macrophages (MΦ), and dendritic cells (DCs). MPS is part of the first line of immune defense against a wide range of pathogens, including viruses, such as the human respiratory syncytial virus (hRSV). The hRSV is an enveloped virus that belongs to the Pneumoviridae family, Orthopneumovirus genus. This virus is the main etiological agent causing severe acute lower respiratory tract infection, especially in infants, children and the elderly. Human RSV can cause bronchiolitis and pneumonia and it has also been implicated in the development of recurrent wheezing and asthma. Monocytes, MΦ, and DCs significantly contribute to acute inflammation during hRSV-induced bronchiolitis and asthma exacerbation. Furthermore, these cells seem to be an important component for the association between hRSV and reactive airway disease. After hRSV infection, the first cells encountered by the virus are respiratory epithelial cells, alveolar macrophages (AMs), DCs, and monocytes in the airways. Because AMs constitute the predominant cell population at the alveolar space in healthy subjects, these cells work as major innate sentinels for the recognition of pathogens. Although adaptive immunity is crucial for viral clearance, AMs are required for the early immune response against hRSV, promoting viral clearance and controlling immunopathology. Furthermore, exposure to hRSV may affect the phagocytic and microbicidal capacity of monocytes and MΦs against other infectious agents. Finally, different studies have addressed the roles of different DC subsets during infection by hRSV. In this review article, we discuss the role of the lung MPS during hRSV infection and their involvement in the development of bronchiolitis.

28 October 2016 in Virulence
Verified
Journal Article
Closed access
AGAndrea E González
Andrea E González
MLMargarita K Lay
Margarita K Lay
EJEvelyn L. Jara
Evelyn L. Jara
JEJanyra A Espinoza
Janyra A Espinoza
RGRoberto S Gómez
Roberto S Gómez
AKAlexis Kalergis
Alexis Kalergis
Human Respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV) are the two major etiological viral agents of lower respiratory tract diseases, affecting mainly infants, young children and the elderly. Although the infection of both viruses trigger an antiviral immune response that mediate viral clearance and disease resolution in immunocompetent individuals, the promotion of long-term immunity appears to be deficient and reinfection are common throughout life. A possible explanation for this phenomenon is that hRSV and hMPV, can induce aberrant T cell responses, which leads to exacerbated lung inflammation and poor T and B cell memory immunity. The modulation of immune response exerted by both viruses include different strategies such as, impairment of immunological synapse mediated by viral proteins or soluble factors, and the induction of pro-inflammatory cytokines by epithelial cells, among others. All these viral strategies contribute to the alteration of the adaptive immunity in order to increase the susceptibility to reinfections. In this review, we discuss current research related to the mechanisms underlying the impairment of T and B cell immune responses induced by hRSV and hMPV infection. In addition, we described the role each virulence factor involved in immune modulation caused by these viruses.